Jim Cramer Broke Down 16 Stocks Including Pharma Plays for Rising Oil

Page 4 of 10

12. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

Jim Cramer reviewed Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) while breaking down 16 stocks for a market facing higher energy costs and economic uncertainty. When a caller asked about the stock during the lightning round, Cramer said:

Okay, I think we, I have to tell you, I think that this company is real. It’s doing better than people realize. It is speculative. I bless it. I bless it as a spec. You can get one spec, as we say in How to Make Money in Any Market. You can get one spec, and that’s the spec that I would buy for you.

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is a biotechnology company that creates therapies to help patients with hematologic disorders and cancer. The company offers treatments for conditions such as immune thrombocytopenia and acute myeloid leukemia and is also developing new inhibitors for autoimmune and inflammatory diseases.

Page 4 of 10